jeudi 12 août 2004
  0 Réponses
  3K Visites
POST 00705E : GLASS SYRINGES DISPOSAL Follow-up on Posts 00696E, 00700E and 00704E 12 August 2004 _______________________________ Philippe Jaillard (mailto:[email protected]) from AMP replies to Anthony Battersby's message (Post 00700E) _______________________________ Dear Anthony, Thank you for your answer and sorry to react so lately, I was in the field out of connection. You give a simple but relevant advice : not using this presentation if you don't have the means to deal with its destruction. Unfortunately, some countries have some "good deal" with pharmaceutic industry which is ready to sell for affordable price (and sometime as a donation for a limited time) some unadapted vaccine presentation. This is our role to advise health authorities of these countries to look at all aspects of immunization activities before ordering or accepting any kind of presentation. I am not sure that national regulatory authorities also provide criteria for elimination of a candidate vaccine for qualification. Regards, Philippe ______________________________________________________________________________ Visit the TECHNET21 Website at http://www.technet21.org You will find instructions to subscribe, a direct access to archives, links to reference documents and other features. ______________________________________________________________________________ To UNSUBSCRIBE, send a message to : mailto:[email protected] Leave the subject area BLANK In the message body, write unsubscribe TECHNET21E ______________________________________________________________________________ The World Health Organization and UNICEF support TechNet21. The TechNet21 e-Forum is a communication/information tool for generation of ideas on how to improve immunization services. It is moderated by Claude Letarte and is hosted in cooperation with the Centre de coopération internationale en santé et développement, Québec, Canada (http://www.ccisd.org) ______________________________________________________________________________
Il n'y a pas encore de réponse à ce message.